# Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure

> **NCT04983043** · PHASE2 · COMPLETED · sponsor: **Tasly Pharmaceutical Group Co., Ltd** · enrollment: 228 (actual)

## Conditions studied

- Chronic Heart Failure With Reduced Ejection Fraction

## Interventions

- **DRUG:** Low dose QiShen YiQi Dripping Pills 3 bags
- **DRUG:** High dose QiShen YiQi Dripping Pills 3 bags
- **DRUG:** QiShen YiQi Dripping Pills placebo 3 bags

## Key facts

- **NCT ID:** NCT04983043
- **Lead sponsor:** Tasly Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-10
- **Primary completion:** 2024-11-27
- **Final completion:** 2024-11-27
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04983043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04983043, "Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04983043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*